2014年甘肃医学继续教育——全员培训 2013年全国抗菌药物临床应用专项整治活动方案解读. 考试题及答案（Continuing medical education in Gansu in 2014 -- Interpretation of the national special trainin...docVIP

2014年甘肃医学继续教育——全员培训 2013年全国抗菌药物临床应用专项整治活动方案解读. 考试题及答案（Continuing medical education in Gansu in 2014 -- Interpretation of the national special training program for clinical application of antibiotics in 2013 Interpretation of the clinical application of antibacterial drugs management measures 1, for emergency rescue dying patients, physicians can leapfrog the use of antibacterial drugs. The indications for drug use should be recorded in detail and the necessary procedures for the leapfrog use of antibiotics should be carried out within (or) hours within 24 A, 48 B, 24 C, 12 D, 6 2, the clinical application of antibacterial drugs management measures (CO) (Chapter) 6, 59 A, 6, 69 B, 7, 59 C, 7, 69 D, 6, 59 3, the clinical use of antibacterial drugs and graded management. According to the safety, efficacy, bacterial resistance, price and other factors, antibacterial drugs are divided into (grade) Three A, three B, four C, five D, six 4, the clinical application of antibacterial drugs management measures (the first chapter) clear the applicable scope of four A, six B, five C, four D, three 5, a special use level of antibacterial drugs narrative is wrong (low price) of antibacterial drugs A, need to strictly control the use, to avoid excessive bacteria produce antimicrobial resistance B, with obvious or severe adverse reactions, antibacterial drugs should not be arbitrarily used C, cheap antibacterial drugs The D of antibacterial drugs, the curative effect and safety of the clinical data of less 6, () refers to the long-term clinical application proved safe and effective, and have a greater impact on bacterial drug resistance, or relatively high price of antibacterial drugs Limiting the use of antimicrobial agents A, non special grade antibiotics B, restricted use of antimicrobial agents C, special grade antibiotics D, non restricted use of antimicrobial agents 7, antibacterial drugs clinical application management measures the third chapter thirty-second points out that